August 2, 2007
Medical diagnostic test maker Beckman Coulter Inc. posted a 56% jump in second-quarter earnings on demand for its genetic testing systems. Net income increased to $69.4 million, or $1.09 a share, from $44.6 million, or 70 cents, a year earlier. Quarterly revenue rose nearly 12% to $689.7 million. Shares of Beckman Coulter gained 4 cents to $70.70.
March 26, 2007 |
Beckman Coulter Inc., a Fullerton company that makes testing instruments used in hospital labs, announced Sunday that it would acquire another biomedical firm, Biosite Inc., for $1.55 billion. In a combination that would strengthen its position in the medical diagnostic field, Beckman said it would acquire all the San Diego company's stock in a cash offer of $85 a share -- a 53% premium over Biosite's closing stock price of $55.38 on Friday.
November 2, 2006 |
Beckman Coulter Inc. said third-quarter profit jumped 31%, mainly on proceeds from the sale of its stake in Agencourt Bioscience Corp. in July and a legal settlement. The Fullerton company earned $47.4 million, or 74 cents a share, compared with $36.2 million, or 56 cents, a year earlier. Revenue rose 6% to $631.2 million. Excluding the sale, the company's profit would have slipped to 28 cents a share, as charges including a $27.5-million payment to Roche Diagnostic Corp.
October 3, 2006 |
Beckman Coulter Inc. said it would buy Lumigen Inc., a maker of chemicals used in diagnostics and scientific research, for $185 million in cash. The transaction is expected to have no effect on Beckman Coulter's financial results this year and to add at least 2 cents a share to earnings next year, the Fullerton company said. The laboratory equipment maker accounted for 40% of Southfield, Mich.-based Lumigen's $33 million in revenue last year, the companies said.
August 3, 2006 |
Beckman Coulter Inc. said its second-quarter profit fell on higher expenses and a decline in sales in Japan and China. The Fullerton maker of laboratory equipment, genetic testing kits and products used in drug discovery posted net income of $44.6 million, or 70 cents a share, down from $55.2 million, or 85 cents, a year ago. Sales fell to $616.3 million from $618.8 million last year. Beckman revised its outlook downward for the rest of the year to reflect slow growth in Asia.
July 18, 2006
Beckman Coulter Inc., a Fullerton-based maker of medical instruments whose audit committee had been reviewing claims by a former employee related to accounting issues, said that the committee found no accounting irregularities and that no adjustments were needed to its financial statements.